Physician profile
Jawed Iqbal
NPI 1205893930
$1,288.20
in general payments reported to CMS, 2019-2025
18 companies · $126 in 2025
The $126 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2021: $155 · 2022: $173 · 2023: $240 · 2024: $331 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $125.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2024 | Libtayo |
| Pharming Healthcare, INC. | $124.74 | 2023 | Joenja |
| Blueprint Medicines Corporation | $121.59 | 2024 | Ayvakit |
| Rigel Pharmaceuticals, INC. | $117.90 | 2019 | |
| Corium, LLC | $114.01 | 2022-2024 | Azstarys |
| Astrazeneca Pharmaceuticals Lp | $93.85 | 2019 | |
| Glaxosmithkline, LLC. | $92.22 | 2022-2025 | Bexsero, Pediarix, Penmenvy |
| Supernus Pharmaceuticals, INC. | $87.86 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $61.82 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $45.92 | 2023-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Seqirus USA INC | $36.91 | 2025 | Flucelvax |
| Sanofi-Aventis U.S. LLC | $34.27 | 2024 | |
| Sanofi Pasteur INC. | $32.90 | 2022 | |
| Collegium Pharmaceutical, INC. | $22.75 | 2025 | Jornay Pm |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $18.98 | 2019 | |
| Verrica Pharmaceuticals INC. | $18.69 | 2025 | Ycanth |
| Cranial Technologies, INC | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jawed Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.